¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Morbidity and mortality weekly report. Surveillance summaries / CDC."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® mortality ÇÑ±Û »ç¸Á·ü
¼³¸í   
  ¾î´À Àα¸Áý´ÜÀ» ´ë»óÀ¸·Î ÇÑ 1³â°£ÀÇ »ç¸ÁÀÚ¼ö°¡ ±× ÇØÀÇ ±× Àα¸Áý´Ü Àüü Àα¸¿¡ ´ëÇÏ¿© Â÷ÁöÇϴ ºñÀ². º¸Åë Àα¸ 1,000¸í¿¡ ´ëÇÑ ¼ýÀڷΠ³ªÅ¸³½´Ù. ±×·¯³ª ¿øÀκ° »ç¸Á·üÀº ÆíÀÇ»ó Àα¸ 10¸¸¸íÀ» ´ë»óÀ¸·Î ³ªÅ¸³½´Ù. »ç¸Á·üÀº ¿¬Â÷-Áö¿ª-Á÷¾÷-¼ºº° µî¿¡ µû¶ó ´Ù¸£±â ¶§¹®¿¡, ¾î´À Áý´ÜÀ» ´Ù¸¥ Áý´Ü°ú »ç¸ÁÀÇ ºóµµ¸¦ ºñ±³ÇÒ ¶§´Â Á¶Á¤»ç¸Á·ü(adjusted death rate)À» »ç¿ëÇÑ´Ù. Áï ÇÑ Áý´ÜÀÇ ¿¬·Éº° »ç¸Á·üÀ» ±¸ÇÑ µÚ¿¡ ÀÏÁ¤ÇÑ ¿¬·É±¸¼ºÀ» °¡Áø Ç¥ÁØÀα¸ÀÇ »ç¸Á·ü°ú ºñ±³Çϴ °ÍÀÌ´Ù. À̸¦ Á¶Á¤»ç¸Á·üÀ̶ó Çϸç, Ã³À½¿¡ ¸»ÇÑ »ç¸Á·üÀº À̰Ͱú ´ëºñÇѴٴ ¶æ¿¡¼­ Á¶»ç¸Á·üÀ̶ó ÇÑ´Ù.
¿µ¹® morbidity ÇÑ±Û ÀÌȯ·ü
¼³¸í   
  º´¿¡ °É¸®´Â Á¤µµ¸¦ Ç¥½ÃÇϴ Åë°èÀû ÁöÇ¥. Áï, ¾î¶² °¨¿°¿¡ ´ëÇÑ Á¢ÃËÀ̳ª, È¤Àº ¹æ»ç¼± µî¿¡ Æø·ÎµÇ¾úÀ» ¶§, ¾î¶² º´À̳ª ¼Õ»óÀ» ÀÔ°Ô µÉ Á¤µµ¸¦ ¸»ÇÑ´Ù. ¾î¶² º´Àû»óŸ¦ °¡Áö°í Àִ »óŸ¦ Åë°èÀû Àǹ̷Π¾µ¶§ »ç¿ëÇÑ´Ù. ÀÌ·± °³³äÀº ¿¹¸¦ µé¾î, Ä¡·á¹æ»ç¼±°ú¿¡¼­´Â ÇʼöÀûÀÌ µÈ´Ù. ¿Ö³ÄÇϸ頾Ͽ¡ ´ëÇ×ÇØ ¾²´Â ¹æ»ç¼±Àº ´ç¿¬È÷ Á¤»óÀûÀΠÁ¶Á÷¿¡µµ Çظ¦ ¹ÌÄ¥ °ÍÀ̹ǷÎ, ÀÌ Á¤»óÀûÀΠÁ¶Á÷¿¡ ¹ÌÄ¥ ÀÌȯ·üÀ» ÃּҷΠÇϰí, ¾ÏÀÇ Ä¡·á¸¦ ½ÃÇàÇØ¾ß Çϱ⠶§¹®ÀÌ´Ù.
¿µ¹® Dilatation and Curettage(D & C) ÇÑ±Û Àڱñܾ¼ú, ÀڱøñÈ®Àå
¼³¸í   
  ÀÚ±ÃÀ̶õ Å¾ư¡ ¼öŵǾ ºÐ¸¸Àü±îÁö ¹ßÀ°ÇÏ°í ¼ºÀåÇϴ °ø°£ÀÌ´Ù. Àڱüӿ¡ º´º¯ÀÌ ÀÖ¾î ÀÓ½ÅÀÌ °è¼ÓµÉ ¼ö ¾ø°Å³ª ¾Æ´Ï¸é ´Ù¸¥ ÀÌÀ¯·Î ÀӽŵǾî Àִ Å¾Ƹ¦ Á¦°ÅÇϰíÀÚ ÇÒ °æ¿ì¿¡ »ç¿ëµÇ´Â ¹æ¹ýÀÌ´Ù. ¿©±â¼­ ±Ü¾î³»±â À§ÇÏ¿©´Â ¿ì¼± ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇϴ ÀڱøñÀ» È®Àå½ÃÄѾߠÇÑ´Ù. ¿©±â¿¡´Â ±Þ¼ÓÈ÷ È®ÀåÀ» ½ÃµµÇϴ ¹ý°ú ¼­¼­È÷ È®ÀåÀ» ½ÃµµÇϴ 2°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀڱøñÀ» ±Þ¼ÓÈ÷ È®ÀåÇÒ ¶§´Â Çì°¡¸£ ¸ñ°üÈ®Àå±â(Hegar's dilatator)¸¦ »ç¿ëÇÑ´Ù. À̰ÍÀº ÀÛÀº ±Ý¼Ó¸·´ë·Î ÀÛÀº Å©±âºÎÅÍ Å« Å©±â±îÁö ´Ù¾çÇÑ Å©±â°¡ À־ ¿ì¼± ÀÛÀº ¸·´ë·Î ½ÃÀÛÇÏ¿© Á¡Á¡ Å« Å©±âÀÇ ¸·´ë¸¦ Àڱøñ¿¡ ³Ö¾î¼­ ÀڱøñÀ» È®Àå½ÃŲ´Ù. ¼­¼­È÷ È®Àå½Ãų ¶§´Â Laminaria tent¸¦ ¸ñ°ü¿¡ »ðÀÔÇϴ ¹æ¹ýÀ» »ç¿ëÇÑ´Ù. Laminaria tent¶õ ÇØÃʷΠ¸¸µç ÀÛÀº ¸·´ë·Î ¼öºÐÀ» Èí¼öÇϸé Á¡Á¡ ´Ã¾î³ª´Â ¼ºÁúÀÌ ÀÖ´Ù. À̰ÍÀ» ÀÚ±ÃÀÇ ¸ñ¿¡ ³ÖÀ¸¸é À̰ÍÀÌ ¼öºÐÀ» Èí¼öÇÏ¿© ´Ã¾î³ª¹Ç·Î ÃµÃµÈ÷ ÀÚ±ÃÀÇ ¸ñÀÌ ´Ã¾î³­´Ù. ÀڱøñÀÌ ÃæºÐÈ÷ ´Ã¾î³ª¸é ±× ¼ÓÀ¸·Î ³¡ÀÌ ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ ³Ö¾î¼­ ÀڱüÓÀÇ º´º¯À̳ª ÀӽŵȠžƸ¦ ±Ü¾î³»´Âµ¥ ¿©±â¿¡ »ç¿ëµÇ´Â ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ Å¥·¿À̶ó°í ÇÑ´Ù. Ãʱâ ÀÓ½ÅÁßÀý Áï À¯»ê°ú °°Àº ÀӽŰú °ü·ÃµÈ °æ¿ì»Ó¸¸ ¾Æ´Ï¶ó, ºñÀӽŠÀÚ±ÃÀÇ Àڱ󻸷Á¶Á÷ÀǠäÃë ¹× Á¦°Å¸¦ À§Çؼ­µµ ÇàÇØÁö´Â ¼ö±âÀÌ´Ù. À̴ ¿øÄ¢ÀûÀ¸·Î ¸¶ÃëÇÏ¿¡ ½Ç½ÃµÇ´Â °ÍÀ¸·Î Àڱøñ°üÀ» È®ÀåÇÏ°í ±â±¸·Î Àڱà³»¿ë¹°À» Á¦°ÅÇϰí Å¥·¿À¸·Î Àڱ󻺮À» ±ú²ýÀÌ ÇÑ´Ù. ÀÚ±Ãõ°øÀ̳ª ÀڱøñÀÇ ÆÄ¿­ µîÀÇ À§ÇèÀÌ µû¸£¸ç, ¼ö¼úÈÄ °¨¿° ¶Ç´Â ÃâÇ÷ µî¿¡ ´ëÇÑ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • case report
    Áõ·Êº¸°í, »ç·Êº¸°í
  • medical examination report
    ÀÇÇÐÀû°Ë»çº¸°í, °Ç°­Áø´Ü¼­
  • report
    º¸°í
  • epidemiological surveillance
    ¿ªÇа¨½Ã
  • immune surveillance
    ¸é¿ª°¨½Ã
  • immunological surveillance
    ¸é¿ª°¨½Ã
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • post-marketing surveillance
    ½ÃÆÇÈĺÎÀÛ¿ë°¨½Ã
  • surveillance
    °¨½Ã, °¨µ¶
  • case morbidity rate
    Áõ·ÊÀÌȯÀ²
  • morbidity
    1. ÀÌȯ 2. ÀÌȯÀ²
  • morbidity rate
    ÀÌȯÀ²
  • morbidity statistics
    ÀÌȯÅë°è
  • morbidity survey
    ÀÌȯÀ²Á¶»ç
  • radiation morbidity scoring criteria
    ¹æ»ç¼±ÀÌȯ°è»êÁ¡±âÁØ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diphteria and tetanus toxoids and acellular pert vaccine
    °³·®µðÇÇÆ¼
  • surveillance
    °¨½Ã
  • report
    º¸°í
  • case report
    Áõ·Êº¸°í
  • morbidity
    1. ÀÌȯ, 2. ÀÌȯÀ²
  • case morbidity rate
    Áõ·ÊÀÌȯÀ²
  • morbidity rate
    ÀÌȯ·ü
  • kidney ureter and bladder
    ÄáÆÏ¿ä°ü¹æ±¤´Ü¼øÃÔ¿µ
  • dilatation and curettage
    Àڱñܾ¼ú, ÀÚ±Ã¼ÒÆÄ¼ú
  • peritoneal oocyte and sperm transfer
    »ý½Ä¼¼Æ÷º¹°­³»À̽Ä, »ý½Ä¼¼Æ÷º¹°­³»Àü´Þ
  • mortality
    »ç¸Á·ü
  • neonatal mortality
    ½Å»ý¾Æ»ç¸Á·ü
  • infant mortality rate
    ¿µ¾Æ»ç¸Á·ü
  • mortality rate
    »ç¸Á·ü
  • operative mortality rate
    ¼ö¼ú»ç¸Á·ü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • case report
    Áõ·Êº¸°í
  • medical examination report
    ÀÇÇÐÀû°Ë»çº¸°í, °Ç°­Áø´Ü¼­
  • report
    º¸°í
  • case morbidity rate
    Áõ·ÊÀÌȯÀ²
  • radiation morbidity scoring criteria
    ¹æ»ç¼±ÀÌȯ°è»êÁ¡±âÁØ
  • morbidity rate
    ÀÌȯÀ²
  • morbidity statistics
    ÀÌȯÅë°è
  • morbidity survey
    ÀÌȯÀ²Á¶»ç
  • specific morbidity rate
    ƯÀÌÀÌȯÀ²
  • surveillance data
    °ü¸®Á¤º¸Á¶»çÀÚ·á
  • epidemiological surveillance
    ¿ªÇа¨½Ã,
  • immune surveillance
    ¸é¿ª°¨½Ã
  • immunological surveillance
    ¸é¿ª°¨½Ã
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • post-marketing surveillance
    ½ÃÆÇÈĺÎÀÛ¿ëÁ¶»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accident report
    »ç°Çº¸°í¼­.
  • radiation morbidity scoring criteria
    ¹æ»ç¼±ÀÌȯ°è»êÁ¡±âÁØ
  • hoof and mouth disease =foot and mouth d.
    ±¸Á¦(¿ª)(Ï¢ð´æ¹) º´.
  • infant mortality rate
    ¿µ¾Æ»ç¸Á·ü.
  • population mortality table
    ±¹¹Î»ý¸íÇ¥(Ë´ËÑË×ËḬ̂), ±¹¹Î»ç¸Á·üÇ¥(Ë´ËÑË×ËÎ Ëô̰).
  • postneonatal mortality rate
    ÈĽŻý¾Æ»ç¸Á·ü(Ì·ËàË×ËâË×ËÎËô).
  • PMS : post marketing surveillance
    ½ÃÆÇÈÄ ºÎÀÛ¿ëÁ¶»ç.
  • immune surveillance
    ¸é¿ª°¨½Ã
  • immune surveillance
    ¸é¿ª[ÇÐÀû]°¨½Ã±âÀü
  • immunologic surveillance
    ¸é¿ª°¨½Ã(±â±¸).
  • immunological surveillance
    ¸é¿ª°¨½Ã(±â±¸)(ÊÙ˧Ëà˻˴), ¸é¿ªÁ¶»ç.
  • immunological surveillance
    ¸é¿ª°¨½Ã(±â±¸)(¡­ÊøãÊѦϰ), ¸é¿ªÁ¶»ç.
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • post marketing surveillance
    ½ÃÆÇÈÄ ºÎÀÛ¿ëÁ¶»ç
  • DSM-I=Diagnostic and Statistical Manual of Mental Disorders-I
    Á¤½ÅÀå¾Ö(º´)Áø´ÜÅë°èÆí¶÷ Á¦ 1ÆÇ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • calculated date of confinement =CDC
    ºÐ¸¸¿¹Á¤ÀÏ(ÝÂØ´çãïÒìí).
  • accident report
    »ç°Çº¸°í¼­.
  • case morbidity rate
    Áõ·ÊÀÌȯÀ²(Ì¡ËçËöÌ·Ëô).
  • case report
    Áõ·Êº¸°í(Áõ¿¹º¸°í).
  • case report
    Áõ·Êº¸°í(ñøçÓÜÃͱ).
  • interim report
    Áß°£º¸°í.
  • medical examination report
    ÀÇÇÐÀû °Ë»çº¸ °í(¡­ÜÃͱ), °Ç°­Áø´Ü¼­(ËíˬòàÓ¨ßö).
  • morbidity
    ÀÌȯÀ²
  • morbidity
    À̺´·ü(ËöËÓËô), ÀÌȯÀ²(ËöÌ·Ëô).
  • morbidity rate
    ÀÌȯÀ²(ËöÌ·Ëô).
  • morbidity statistics
    ÀÌȯÅë°è(ÊÙ̬˭).
  • radiation morbidity scoring criteria
    ¹æ»ç¼±ÀÌȯ°è»êÁ¡±âÁØ
  • result report
    °á°úº¸°í
  • specific morbidity rate
    ƯÁ¤ÀÌȯÀ²(Ì¬Ëø ËöÌ·Ëô).
  • yearly report
    ¿¬º¸(ËçËÓ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Tendon sheath of abductor longus and extenor brevis
    ±ä¾öÁö¹ú¸²±Ù°úªÀº¾öÁöÆï±ÙÈûÁÙÁý
    [¿¾ ¿ë¾î] À幫Áö¿ÜÀü±Ù ¹× ´Ü¹«Áö½Å±Ù°ÇÃÊ
  • Lymph nodes of head and neck
    ¸Ó¸® ¹× ¸ñ¸²ÇÁÀý
    [¿¾ ¿ë¾î] µÎ°æºÎÀÓÆÄÀý
  • White matter (Tracts and Fascicles)
    ¹é»öÁú(½Å°æ·Î¿Í ½Å°æ´Ù¹ß)
    [¿¾ ¿ë¾î] ¹éÁú
  • Fold and fossa
    º¹¸·ÁÖ¸§°ú º¹¸·¿À¸ñ
    [¿¾ ¿ë¾î] º¹¸·ÁÖ¸§°ú º¹¸·¿Í
  • Tendon sheath of extensor digitorum and extensor indicis
    ¼Õ°¡¶ôÆï±Ù°úÁý°ÔÆï±ÙÈûÁÙÁý
    [¿¾ ¿ë¾î] Áö½Å±Ù ¹× ½ÃÁö½Å±Ù°ÇÃÊ
  • Sections of thalamus and metathalamus
    ½Ã»ó ¹× ½Ã»óÈĺÎÀÇ ´Ü¸é
    [¿¾ ¿ë¾î] ½Ã»ó ¹× ½Ã»óÈĺÎÀÇ ´Ü¸é
  • Tracts and fascicles of thalamus
    ½Ã»óÀÇ ½Å°æ·Î ¹× ½Å°æ´Ù¹ß
    [¿¾ ¿ë¾î] ½Ã»ó·Î ¹× ½Ã»ó¼Ó
  • Tracts and fascicles of hypothalamus
    ½Ã»óÇϺÎÀÇ ½Å°æ·Î ¹× ½Å°æ´Ù¹ß
    [¿¾ ¿ë¾î] ½Ã»óÇϺηΠ¹× ½Ã»óÇϺμÓ
  • Period of mature neural groove and immature somite
    ½Å°æ°í¶û¼º¼÷ ¹× ¸öºÐÀý¹Ì¼º¼÷±â
    [¿¾ ¿ë¾î] ½Å°æ±¸Çü¼ºÈÄ±â ¹× Ã¼ÀýÇü¼ºÀü±â
  • Medial and inferior surface
    ¾ÈÂÊ¸é ¹× ¾Æ·¡¸é
    [¿¾ ¿ë¾î] ³»Ãø¸é°ú Çϸé
  • Sacral nerves and coccygeal nerve
    ¾ûÄ¡½Å°æ ¹× ²¿¸®½Å°æ
    [¿¾ ¿ë¾î] õ°ñ½Å°æ ¹× ¹Ì°ñ½Å°æ
  • Lobar and segmental bronchi
    ¿±±â°üÁö¿Í ±¸¿ª±â°üÁö
    [¿¾ ¿ë¾î] ¿±±â°üÁö¿Í ±¸±â°üÁö
  • Muscles of palate and fauces
    ÀÔõÀå ¹× ¸ñ±¸¸Û±ÙÀ°
    [¿¾ ¿ë¾î] ±¸°³ ¹× ±¸Çù±Ù
  • Muscles of palate and fauces
    ÀÔõÀå ¹× ¸ñ±¸¸Û±ÙÀ°
    [¿¾ ¿ë¾î] ±¸°³±Ù ¹× ±¸Çù±Ù
  • Mode and course of progress
    ÁøÇà¾ç½Ä ¹× °úÁ¤
    [¿¾ ¿ë¾î] ÁøÇà¾ç½Ä¹×°úÁ¤
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immune surveillance theory
    ¸é¿ª °¨½Ã ÀÌ·Ð(Øóæ¹ÊøãÊ×âÖå)
  • immunological surveillance theory
    ¸é¿ª °¨½Ã ÀÌ·Ð(Øóæ¹ÊøãÊ×âÖå)
  • ball and stick model
    °ø ¸·´ë ¸ðµ¨
  • breakage and reunion model
    Àý´ÜÀç°áÇÕ(ï·Ó¨î¢Ì¿ùê)¸ðµ¨
  • cut and patch repair
    Àß¶ó±é±â ¼öº¹(áóÜÖ) (ÔÒ) excision repair
  • Dean and Webb method
    µò°ú¿þºê ¹ý(Ûö)
  • Jacob and Monod hypothesis
    Àð°ö¡¤¸ð³ë ¼³(àã)
  • knife and fork model
    ³ªÀÌÇÁÆ÷Å© ¸ðµ¨
  • "Koshland, Nemethy, and Filmer model"
    "ÄÚ½¬·»µå,³×¸ÞƼ,ÇÊ¸Ó ¸ðµ¨"
  • Lavoisier and Laplace law
    ¶óº¸¾ÆÁ¦ ¶óÇÁ¶óÀ̽º¹ýÄ¢(ÛööÎ)
  • lock and key theory
    ÀÚ¹°¼è-¿­¼èÀÌ·Ð(ìµÖå)
  • modification and restriction
    ¼ö½Ä(áóãÞ)°ú Á¦ÇÑ(ð¤ùÚ)
  • "Monod, Wyman, and Changeux model"
    ¸ð³ë.¿ÍÀ̸¸.¼§Á¶¸ðµ¨
  • Park and Johnson method
    ÆÄÅ© Á¸½¼ ¹ý(Ûö)
  • patch and cut repair
    Àý´Ü ºÎ ¼öº¹(ï·Ó¨Ý¾áóÜÖ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • morbidity
    À̺´·ü, ÀÌȯÀ²
  • mortality
    »ç¸Á·ü
  • neonatal mortality
    ½Å»ý¾Æ»ç¸Á(·ü)
  • perinatal mortality
    ÁÖ»ê±â»ç¸Á
  • case report
    Áõ·Êº¸°í
  • preliminary report
    ¿¹º¸, Ãʱ⺸°í
  • report
    º¸°í
  • yearly report
    ¿¬º¸
  • ball and socket joint
    Àý±¸°øÀ̰üÀý
  • ENT [=ear, nose and throat]
    À̺ñÀÎÈİúÇÐ
  • growth and development
    ¼ºÀå°ú ¹ßÀ°
  • infant and child
    ¿µÀ¯¾Æ, À¯¼Ò¾Æ
  • intake and output
    ¼·Ãë¿Í ¹è¼³
  • kidney ureter and bladder [=KUB]
    ½Å-´¢°ü-¹æ±¤ ´Ü¼øÃÔ¿µ
  • KUB [=kidney, ureter and bladder]
    ½Å-´¢°ü-¹æ±¤ ´Ü¼øÃÔ¿µ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MMWR Morbidity and Mortality Weekly Report
PMR patient meta-record; perinatal mortality rate; periodic medical review; physical medicine and rehabi...
MM macromolecule; Maelzels metronome; major medical [insurance]; malignant melanoma; manubrium to malle...
M&M morbidity and mortality
MR Maddox rods; magnetic resistance; magnetic resonance; mandibular reflex; mannose-resistant; may repe...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PTWI Provisional Tolerable Weekly Intake
TIW times weekly
MPM Minor Psychiatric Morbidity
NCS National Co-morbidity Survey
SAS-SR Social Adjustment Scale Self-Report
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 29845
    JournalTitle: Morbidity and mortality weekly report. Surveillance summaries / CDC.
    MedAbbr: MMWR Surveill Summ
    ISSN: 1546-0738
    ESSN:
    IsoAbbr:
    NlmId: 101142015
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • CDA certified dentual assistantÀÇ ¾àÀÚ.

    CDC

    Áúȯ Á¶Àý ¹× ¿¹¹æ ¼¾ÅÍ
    Centers for Disease Control and PreventionÀÇ ¾àÀÚ.
  • epidemiological surveillance
    ¿ªÇÐÀû °¨½Ã
  • morbidity
    À̺´·ü, ÀÌȯÀ², Áúº´À², ÀÌȯ »óÅÂ
    1. Áúȯ¿¡ ÀÌȯµÈ ¶Ç´Â º´ÀûÀÎ »óÅÂ. 2. ¾î¶² Áö¿ª »çȸ¿¡ À־ °Ç°­Àο¡ ´ëÇÑ È¯ÀÚÀÇ ºñÀ². ÀÏÁ¤ ±â°£ ³»¿¡¼­ ÀÌȯÀÚ ¼öÀÇ, ƯÁ¤ Àα¸¿¡ ´ëÇÑ ºñÀ². À̺´À², ¹ßº´À²À̶ó°íµµ ÇÑ´Ù. À̰ÍÀº À¯º´À²ÀÌ Á¤Å¸¦ ³ªÅ¸³»´Â µ¥ ºñÇØ µ¿Å¸¦ ³ªÅ¸³»´Â °ÍÀ̶ó°í ÇÒ ¼ö ÀÖ´Ù. ÀÌ ¼öÄ¡´Â °øÁßÀ§»ýÀÇ ¹ß´Þ ¹× º¸±Þ¿¡ ¹ÐÁ¢ÇÑ °ü°è°¡ ÀÖÀ¸³ª, º´¿¡ °É·ÁÀÖ´ÂÁö ¾î¶² ÁöÀÇ ÆÇÁ¤ÀÌ °ï¶õÇϰí ÀÌ È¯ÀÚ°¡ ¹Ýµå½Ã ±â·ÏµÇ¾î ÀÖ´Ù°íµµ º¼ ¼ö ¾øÀ¸¹Ç·Î ½ÇŸ¦ Á¤È®È÷ ³ªÅ¸³½´Ù°í´Â º¼ ¼ö ¾ø´Ù. 3. Áúº´ÀÇ »óÅÂ. Áúº´ÀÇ ¹ß»ý·ü ȤÀº Àü Àα¸¿¡¼­ÀÇ ¸ðµç Áúº´ÀÇ ¹ßº´ ¼ö.
  • morbidity statistics
    ÀÌȯ Åë°è
  • incident report mechanism
    »ç°Ç º¸°í ±âÀü
  • narrative report
    ÀÓ»ó º¸°í¼­
    ÁÖ¾îÁø ȯÀÚ¿¡ ´ëÇØ ÀÌ·ç¾îÁö´Â ÀÓ»óÀû ¼Ò°ß, Áø´Ü, Ä¡·á¸¦ ÀüüÀûÀ¸·Î ¹¦»çÇÑ ±â·Ï.
  • preliminary report
    ¿¹º¸, Ãʱ⠺¸°í
  • report
    º¸°í
  • maternal mortality rate
    ¸ð¼º »ç¸Á·ü, ÀÓ»êºÎ »ç¸Á·ü
  • mortality rate
    »ç¸Á·ü
  • neonatal mortality rate
    ½Å»ý¾Æ »ç¸Á·ü
  • operative mortality rate
    ¼ö¼ú »ç¸Á·ü
  • perinatal mortality
    ÁÖ»ê±â »ç¸Á
  • toddler mortality rate
    À¯¾Æ »ç¸Á·ü
  • tooth mortality rate
    Ä¡¾Æ »ó½Ç·ü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
weekly 1. Of or pertaining to a week, or week days; as, weekly labour.
2. Coming, happening, or done once a week; hebdomadary; as, a weekly payment; a weekly gazette.
Once a week; by hebdomadal periods; as, each performs service weekly.
Source: Websters Dictionary
(01 Mar 1998)
cancer, colon: screening and surveillance Colon cancer is both preventable and curable. It is preventable by removing precancerous colon polyps. It is curable if early cancer is surgically removed before cancer spread to other parts of the body. Therefore, if screening and surveillance programs were practiced universally, there would be a major reduction in the incidence and mortality of colon cancer.
(12 Dec 1998)
meeting report A published record of the presentations at a meeting of a society, association, or similar body or of transactions at a symposium, colloquium, seminar, workshop, round table, conference, or congress. Mere notification of the date and place of the meeting is not within the scope of this publication type. It is to be used, rather, for the proceedings or transactions of the sessions, often with presentation of papers.
(12 Dec 1998)
technical report A formal report giving details of the investigation and results of a medical or other scientific problem. When issued by a government agency or comparable official body, its contents may be classified, unclassified, or declassified with regard to security clearance. This publication type may also cover a scientific paper or article that records the current state or current position of scientific research and development. If so labelled by the editor or publisher, this publication type may be properly used for journal articles.
(12 Dec 1998)
genes, cdc Genes that code for proteins that regulate the cell division cycle. These genes form a regulatory network that culminates in the onset of mitosis by activating the p34cdc2 protein (protein p34cdc2).
(12 Dec 1998)
CDC The Centres for Disease Control and Prevention (CDC). The American agency charged with tracking and investigating public health trends. Its stated mission is To promote health and quality of life by preventing and controlling disease, injury, and disability. A part of the U.S. Public Health Services (PHS) under the Department of Health and Human Services (HHS), the CDC is based in Atlanta, Georgia. It publishes key health information including weekly data on all deaths and diseases reported in the United States ( Morbidity and Mortality Weekly Report ) and travelers' health advisories.
(12 Dec 1998)
cdc gene <molecular biology> Cell division cycle genes, of which many have now been defined, especially in yeasts.
See cyclin.
(18 Nov 1997)
morbidity A diseased condition or state, the incidence of a disease or of all diseases in a population.
(18 Nov 1997)
morbidity rate The sickness rate, the number of people who are sick or have a disease compared with the number who are well.
(09 Oct 1997)
puerperal morbidity Illness arising during the first 10 days of the postpartum period, i.e., a temperature of 38°C (100.4°F) or more on any two days of the first 10, excluding the first 24 hours.
(05 Mar 2000)
population surveillance <epidemiology> Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy.
(12 Dec 1998)
post-marketing surveillance Procedure implemented after a drug has been licensed for public use, designed to provide information on use and on occurrence of side effects, adverse effects, etc.
(05 Mar 2000)
product surveillance, postmarketing Surveillance of drugs, devices, appliances, etc., for efficacy or adverse effects, after they have been released for general sale.
(12 Dec 1998)
sentinel surveillance Monitoring of rate of occurrence of specific conditions to assess the stability or change in health levels of a population. It is also the study of disease rates in a specific cohort, geographic area, population subgroup, etc. To estimate trends in larger population.
(12 Dec 1998)
surveillance Oversight; watch; inspection; supervision. "That sort of surveillance of which . . . The young have accused the old." (Sir W. Scott)
Origin: F, fr. Surveiller to watch over; sur over + veiller to watch, L. Vigilare. See Sur-, and Vigil.
Source: Websters Dictionary
(01 Mar 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • morbidity
    º´ÀûÀÎ »óÅÂ;ºÒ°ÇÀü ·Î
  • infant mortality
    (1¼¼¹Ì¸¸ÀÇ)À¯¾Æ»ç¸Á·ü 
  • mortality
    Á×À½À» ¸éÇÒ ¼ö ¾øÀ½;Á×¾î¾ß ÇÒ ¿î¸í;»ç¸ÁÀÚ¼ö;»ç¸Á·ü
  • mortality table
    »ç¸Á·ü Åë°èÇ¥
  • surveillance
    °¨½Ã; °¨µ¶
  • electronic surveillance
    ÀüÀÚ °¨½Ã(Á¤º¸ ¼öÁý)
  • immune surveillance
    IMMUNOLOGICAL SURVEILLANCE
  • surveillance
    °¨½Ã;°¨µ¶;under ~ °¨µ¶À» ¹Þ°í
  • weekly
    1 ÁÖ°£ÀÇ
  • semi weekly
    ÁÖ 2ȸ °£Ç๰
  • weekly
    1ÁÖ°£ÀÇ;1ÁÖ°£ °è¼ÓµÇ´Â;ÁÖ 1ȸÀÇ;¸ÅÁÖÀÇ
  • weekly
    ÁÖ1ȸ;¸ÅÁÖ
  • weekly
    ÁÖ°£Áö
  • report
    º¸µµÇÏ´Ù,ÀüÇÏ´Ù,º¸µµ,±â»ç,ÆòÆÇ
  • Economic Report
    (¹Ì±¹ ´ëÅë·ÉÀÇ)°æÁ¦ º¸°í(¿¬ÃÊ¿¡ »óÇÏ ¾ç¿ø¿¡ º¸³¿)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á